Autologous tumor-infiltrating lymphocytes (TIL) therapy
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Autologous tumor-infiltrating lymphocytes (TIL) therapy, covering 2014-11-24 to 2026-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients [Phase 1]